scispace - formally typeset
Journal ArticleDOI

Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Reads0
Chats0
TLDR
Axial tumor site, male sex, and a long history of symptoms were associated with poor response to chemotherapy in univariate and multivariate analysis.
Abstract
PURPOSE: To define prognostic factors for response and long-term outcome for a wide spectrum of osteosarcomas, extending well beyond those of the typical young patient with seemingly localized extremity disease. PATIENTS AND METHODS: A total of 1,702 consecutive newly diagnosed patients with high-grade osteosarcoma of the trunk or limbs registered into the neoadjuvant studies of the Cooperative Osteosarcoma Study Group before July 1998 were entered into an analysis of demographic, tumor-related, and treatment-related variables, response, and survival. The intended therapeutic strategy included preoperative and postoperative chemotherapy with multiple agents as well as surgery of all operable lesions. RESULTS: Axial tumor site, male sex, and a long history of symptoms were associated with poor response to chemotherapy in univariate and multivariate analysis. Actuarial 10-year overall and event-free survival rates were 59.8% and 48.9%. Among the variables assessable at diagnosis, patient age (actuarial 10-y...

read more

Citations
More filters

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

TL;DR: Lymphedema is a common complication after treatment for breast cancer and factors associated with increased risk of lymphedEMA include extent of axillary surgery, axillary radiation, infection, and patient obesity.
Journal ArticleDOI

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

TL;DR: Biologic, preclinical, and clinical trial efforts will be described along with future international collaborative strategies to improve outcomes for patients who develop this challenging tumor.
Journal ArticleDOI

Osteosarcoma treatment - where do we stand? A state of the art review.

TL;DR: The current state of the art of systemic osteosarcoma therapy is reviewed by focusing on the experiences of cooperative osteosARcoma groups, shedding light on questions and challenges posed by the aggressiveness of the tumor, and potential future directions that may be critical to progress in the prognosis of high-grade osteosArcoma.
Journal ArticleDOI

Biology and Therapeutic Advances for Pediatric Osteosarcoma

TL;DR: The authors review the state of the art management for patients with osteosarcoma in North America and Europe including the use of limb-salvage procedures and reconstruction as well as discuss the etiologic and biologic factors associated with tumor development.
References
More filters
Journal ArticleDOI

Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients

TL;DR: Intensive multiagent chemotherapy and delayed surgery for localized extremity osteosarcoma led to excellent oncologic results in the COSS- studies, and giving doxorubicin and cisplatin by continuous infusions did not result in discernible prognostic disadvantages.
Journal ArticleDOI

Prognostic factors in osteosarcomas. A regression analysis

TL;DR: A multivariate regression analysis of survival data was performed on the retrospective material of 184 osteosarcoma patients treated at the Aarhus and Copenhagen oncology centers, Denmark, from 1963 to 1984, finding that children, adolescents, and adults ages 5 to 25 years had significantly poorer prognosis than young adults 25 to 30 years of age.
Journal ArticleDOI

Targeted Radiotherapy of Osteosarcoma Using 153Sm-Edtmp: A new promising approach

TL;DR: A 35-year-old male with a primary osteosarcoma located in the first lumbar vertebra relapsed with progressive back pain after conventional treatment modalities had failed, and gave targeted radionuclide therapy using 153Sm-EDTMP gave substantial palliative effect.
Journal ArticleDOI

Prognostic factors in bone sarcomas.

TL;DR: For an adolescent patient with non-metastatic extremity disease, there is no consensus regarding prognostic factors at initial presentation, and currently there is thus no established method for dividing them into high- and low risk groups for the purpose of treatment differentiation.
Related Papers (5)